位置:首页 > 蛋白库 > NEBL_HUMAN
NEBL_HUMAN
ID   NEBL_HUMAN              Reviewed;        1014 AA.
AC   O76041; B0YJ45; B9EIM9; E9PRX7; Q2TBD0; Q5VZT2; Q70I54; Q9UIC4;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   03-AUG-2022, entry version 182.
DE   RecName: Full=Nebulette;
DE   AltName: Full=Actin-binding Z-disk protein;
GN   Name=NEBL {ECO:0000312|HGNC:HGNC:16932};
GN   Synonyms=C10orf113 {ECO:0000312|HGNC:HGNC:16932}, LNEBL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart muscle;
RX   PubMed=9733644; DOI=10.1006/jmbi.1998.1999;
RA   Millevoi S., Trombitas K., Kolmerer B., Kostin S., Schaper J., Pelin K.,
RA   Granzier H., Labeit S.;
RT   "Characterization of nebulette and nebulin and emerging concepts of their
RT   roles for vertebrate Z-discs.";
RL   J. Mol. Biol. 282:111-123(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RX   PubMed=10470015;
RX   DOI=10.1002/(sici)1097-0169(199909)44:1<1::aid-cm1>3.0.co;2-8;
RA   Moncman C.L., Wang K.;
RT   "Functional dissection of nebulette demonstrates actin binding of nebulin-
RT   like repeats and Z-line targeting of SH3 and linker domains.";
RL   Cell Motil. Cytoskeleton 44:1-22(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, INTERACTION WITH ZYX, AND
RP   SUBCELLULAR LOCATION (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=15004028; DOI=10.1074/jbc.m310304200;
RA   Li B., Zhuang L., Trueb B.;
RT   "Zyxin interacts with the SH3 domains of the cytoskeletal proteins LIM-
RT   nebulette and Lasp-1.";
RL   J. Biol. Chem. 279:20401-20410(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-795, METHYLATION [LARGE SCALE
RP   ANALYSIS] AT ARG-96 (ISOFORM 2), AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH DES.
RX   PubMed=27733623; DOI=10.1091/mbc.e16-04-0237;
RA   Hernandez D.A., Bennett C.M., Dunina-Barkovskaya L., Wedig T.,
RA   Capetanaki Y., Herrmann H., Conover G.M.;
RT   "Nebulette is a powerful cytolinker organizing desmin and actin in mouse
RT   hearts.";
RL   Mol. Biol. Cell 27:3869-3882(2016).
RN   [11]
RP   VARIANTS HIS-187; VAL-351; LYS-654 AND ALA-728.
RX   PubMed=11140941; DOI=10.1007/s004390000389;
RA   Arimura T., Nakamura T., Hiroi S., Satoh M., Takahashi M., Ohbuchi N.,
RA   Ueda K., Nouchi T., Yamaguchi N., Akai J., Matsumori A., Sasayama S.,
RA   Kimura A.;
RT   "Characterization of the human nebulette gene: a polymorphism in an actin-
RT   binding motif is associated with nonfamilial idiopathic dilated
RT   cardiomyopathy.";
RL   Hum. Genet. 107:440-451(2000).
CC   -!- FUNCTION: Binds to actin and plays an important role in the assembly of
CC       the Z-disk. May functionally link sarcomeric actin to the desmin
CC       intermediate filaments in the heart muscle sarcomeres
CC       (PubMed:27733623). Isoform 2 might play a role in the assembly of focal
CC       adhesion (PubMed:15004028). {ECO:0000269|PubMed:15004028,
CC       ECO:0000269|PubMed:27733623}.
CC   -!- SUBUNIT: Isoform 2 interacts with ZYX (Zyxin) (PubMed:15004028).
CC       Interacts (via nebulin repeats 1-5) with DESM (via rod region)
CC       (PubMed:27733623). {ECO:0000269|PubMed:15004028,
CC       ECO:0000269|PubMed:27733623}.
CC   -!- INTERACTION:
CC       O76041; Q15027: ACAP1; NbExp=3; IntAct=EBI-2880203, EBI-751746;
CC       O76041; P05067: APP; NbExp=3; IntAct=EBI-2880203, EBI-77613;
CC       O76041; P54253: ATXN1; NbExp=3; IntAct=EBI-2880203, EBI-930964;
CC       O76041; Q86Z20: CCDC125; NbExp=3; IntAct=EBI-2880203, EBI-11977221;
CC       O76041; Q8NHQ1: CEP70; NbExp=3; IntAct=EBI-2880203, EBI-739624;
CC       O76041; P50570-2: DNM2; NbExp=3; IntAct=EBI-2880203, EBI-10968534;
CC       O76041; Q8IZU0: FAM9B; NbExp=3; IntAct=EBI-2880203, EBI-10175124;
CC       O76041; Q53SE7: FLJ13057; NbExp=3; IntAct=EBI-2880203, EBI-10172181;
CC       O76041; P14136: GFAP; NbExp=3; IntAct=EBI-2880203, EBI-744302;
CC       O76041; Q53GS7: GLE1; NbExp=3; IntAct=EBI-2880203, EBI-1955541;
CC       O76041; Q08379: GOLGA2; NbExp=4; IntAct=EBI-2880203, EBI-618309;
CC       O76041; Q9NYA3: GOLGA6A; NbExp=3; IntAct=EBI-2880203, EBI-11163335;
CC       O76041; Q9NSC5: HOMER3; NbExp=3; IntAct=EBI-2880203, EBI-748420;
CC       O76041; P42858: HTT; NbExp=18; IntAct=EBI-2880203, EBI-466029;
CC       O76041; O60333-2: KIF1B; NbExp=3; IntAct=EBI-2880203, EBI-10975473;
CC       O76041; Q9BVG8-5: KIFC3; NbExp=3; IntAct=EBI-2880203, EBI-14069005;
CC       O76041; P02545: LMNA; NbExp=3; IntAct=EBI-2880203, EBI-351935;
CC       O76041; Q9BRK4: LZTS2; NbExp=3; IntAct=EBI-2880203, EBI-741037;
CC       O76041; Q9Y6D9: MAD1L1; NbExp=7; IntAct=EBI-2880203, EBI-742610;
CC       O76041; Q8TD10: MIPOL1; NbExp=3; IntAct=EBI-2880203, EBI-2548751;
CC       O76041; P07196: NEFL; NbExp=3; IntAct=EBI-2880203, EBI-475646;
CC       O76041; P35240: NF2; NbExp=3; IntAct=EBI-2880203, EBI-1014472;
CC       O76041; Q86Y26: NUTM1; NbExp=3; IntAct=EBI-2880203, EBI-10178410;
CC       O76041; Q7Z412: PEX26; NbExp=3; IntAct=EBI-2880203, EBI-752057;
CC       O76041; Q4G0R1: PIBF1; NbExp=3; IntAct=EBI-2880203, EBI-14066006;
CC       O76041; Q92569: PIK3R3; NbExp=3; IntAct=EBI-2880203, EBI-79893;
CC       O76041; P49810: PSEN2; NbExp=3; IntAct=EBI-2880203, EBI-2010251;
CC       O76041; P47897: QARS1; NbExp=3; IntAct=EBI-2880203, EBI-347462;
CC       O76041; Q96R06: SPAG5; NbExp=3; IntAct=EBI-2880203, EBI-413317;
CC       O76041; Q7Z699: SPRED1; NbExp=3; IntAct=EBI-2880203, EBI-5235340;
CC       O76041; Q13077: TRAF1; NbExp=4; IntAct=EBI-2880203, EBI-359224;
CC       O76041; Q12933: TRAF2; NbExp=7; IntAct=EBI-2880203, EBI-355744;
CC       O76041; P14373: TRIM27; NbExp=3; IntAct=EBI-2880203, EBI-719493;
CC       O76041; P18206-2: VCL; NbExp=3; IntAct=EBI-2880203, EBI-11027067;
CC       O76041; Q8N5A5-2: ZGPAT; NbExp=3; IntAct=EBI-2880203, EBI-10183064;
CC       O76041; B2R8Y4; NbExp=3; IntAct=EBI-2880203, EBI-10175581;
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm
CC       {ECO:0000269|PubMed:15004028}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O76041-1; Sequence=Displayed;
CC       Name=2; Synonyms=LIM-nebulette, LNEBL;
CC         IsoId=O76041-2; Sequence=VSP_043816, VSP_043817, VSP_043818;
CC   -!- TISSUE SPECIFICITY: Abundantly expressed in cardiac muscle, but not in
CC       skeletal or smooth muscle. Localized to Z-lines in cardiac cells and to
CC       dense bodies in nonmuscle cells. Isoform 2 is expressed in non-muscle
CC       cells such as in fibroblasts.
CC   -!- MISCELLANEOUS: [Isoform 2]: Expressed in non-muscle cells. May be
CC       transcribed from an upstream promoter active in non-muscle cells.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI40745.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y16241; CAA76130.1; -; mRNA.
DR   EMBL; Y17673; CAA76810.1; -; mRNA.
DR   EMBL; AF047368; AAF24858.1; -; mRNA.
DR   EMBL; AJ580772; CAE45323.1; -; mRNA.
DR   EMBL; AK295186; BAG58190.1; -; mRNA.
DR   EMBL; EF445000; ACA06022.1; -; Genomic_DNA.
DR   EMBL; EF445000; ACA06023.1; -; Genomic_DNA.
DR   EMBL; EF445000; ACA06024.1; -; Genomic_DNA.
DR   EMBL; EF445000; ACA06026.1; -; Genomic_DNA.
DR   EMBL; AL359175; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL731547; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL157398; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL158160; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471072; EAW86175.1; -; Genomic_DNA.
DR   EMBL; BC110453; AAI10454.1; -; mRNA.
DR   EMBL; BC126132; AAI26133.1; -; mRNA.
DR   EMBL; BC126134; AAI26135.1; -; mRNA.
DR   EMBL; BC140744; AAI40745.1; ALT_SEQ; mRNA.
DR   EMBL; BC144447; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS7133.1; -. [O76041-2]
DR   CCDS; CCDS7134.1; -. [O76041-1]
DR   RefSeq; NP_001010896.2; NM_001010896.2.
DR   RefSeq; NP_001166955.1; NM_001173484.1.
DR   RefSeq; NP_006384.1; NM_006393.2. [O76041-1]
DR   RefSeq; NP_998734.1; NM_213569.2. [O76041-2]
DR   PDB; 4F14; X-ray; 1.20 A; A=955-1014.
DR   PDBsum; 4F14; -.
DR   AlphaFoldDB; O76041; -.
DR   SMR; O76041; -.
DR   BioGRID; 115784; 73.
DR   IntAct; O76041; 57.
DR   MINT; O76041; -.
DR   STRING; 9606.ENSP00000366326; -.
DR   GlyGen; O76041; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O76041; -.
DR   PhosphoSitePlus; O76041; -.
DR   SwissPalm; O76041; -.
DR   BioMuta; C10orf113; -.
DR   BioMuta; NEBL; -.
DR   EPD; O76041; -.
DR   jPOST; O76041; -.
DR   MassIVE; O76041; -.
DR   PaxDb; O76041; -.
DR   PeptideAtlas; O76041; -.
DR   PRIDE; O76041; -.
DR   ProteomicsDB; 50360; -. [O76041-1]
DR   ProteomicsDB; 50361; -. [O76041-2]
DR   ABCD; O76041; 6 sequenced antibodies.
DR   Antibodypedia; 2823; 82 antibodies from 18 providers.
DR   DNASU; 10529; -.
DR   Ensembl; ENST00000377122.9; ENSP00000366326.4; ENSG00000078114.19. [O76041-1]
DR   Ensembl; ENST00000417816.2; ENSP00000393896.2; ENSG00000078114.19. [O76041-2]
DR   GeneID; 10529; -.
DR   KEGG; hsa:10529; -.
DR   MANE-Select; ENST00000377122.9; ENSP00000366326.4; NM_006393.3; NP_006384.1.
DR   UCSC; uc001iqi.4; human. [O76041-1]
DR   CTD; 10529; -.
DR   DisGeNET; 10529; -.
DR   GeneCards; C10orf113; -.
DR   GeneCards; NEBL; -.
DR   HGNC; HGNC:16932; NEBL.
DR   HPA; ENSG00000078114; Tissue enriched (heart).
DR   MalaCards; NEBL; -.
DR   MIM; 605491; gene.
DR   neXtProt; NX_O76041; -.
DR   OpenTargets; ENSG00000078114; -.
DR   Orphanet; 155; NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy.
DR   PharmGKB; PA134981177; -.
DR   VEuPathDB; HostDB:ENSG00000078114; -.
DR   eggNOG; ENOG502TDXB; Eukaryota.
DR   eggNOG; KOG1702; Eukaryota.
DR   GeneTree; ENSGT00940000156390; -.
DR   HOGENOM; CLU_014106_0_0_1; -.
DR   InParanoid; O76041; -.
DR   OMA; DHSMERY; -.
DR   OrthoDB; 1305510at2759; -.
DR   PhylomeDB; O76041; -.
DR   TreeFam; TF319104; -.
DR   TreeFam; TF353304; -.
DR   PathwayCommons; O76041; -.
DR   SignaLink; O76041; -.
DR   BioGRID-ORCS; 10529; 4 hits in 1076 CRISPR screens.
DR   BioGRID-ORCS; 387638; 6 hits in 1040 CRISPR screens.
DR   ChiTaRS; NEBL; human.
DR   GenomeRNAi; 10529; -.
DR   Pharos; O76041; Tbio.
DR   PRO; PR:Q5VZT2; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; O76041; protein.
DR   Bgee; ENSG00000078114; Expressed in heart right ventricle and 196 other tissues.
DR   ExpressionAtlas; O76041; baseline and differential.
DR   Genevisible; O76041; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0031674; C:I band; NAS:UniProtKB.
DR   GO; GO:0001725; C:stress fiber; IDA:UniProtKB.
DR   GO; GO:0030018; C:Z disc; IDA:UniProtKB.
DR   GO; GO:0051015; F:actin filament binding; IDA:UniProtKB.
DR   GO; GO:0008092; F:cytoskeletal protein binding; IDA:UniProtKB.
DR   GO; GO:0031005; F:filamin binding; IPI:UniProtKB.
DR   GO; GO:0008307; F:structural constituent of muscle; NAS:UniProtKB.
DR   GO; GO:0005523; F:tropomyosin binding; IPI:UniProtKB.
DR   GO; GO:0071691; P:cardiac muscle thin filament assembly; IMP:UniProtKB.
DR   CDD; cd11935; SH3_Nebulette_C; 1.
DR   InterPro; IPR035631; Nebulette_SH3.
DR   InterPro; IPR000900; Nebulin_repeat.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   Pfam; PF00880; Nebulin; 9.
DR   Pfam; PF14604; SH3_9; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00227; NEBU; 23.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS51216; NEBULIN; 23.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Actin-binding; Alternative splicing; Cytoplasm; Methylation;
KW   Reference proteome; Repeat; SH3 domain.
FT   CHAIN           1..1014
FT                   /note="Nebulette"
FT                   /id="PRO_0000096774"
FT   REPEAT          29..63
FT                   /note="Nebulin 1"
FT   REPEAT          64..99
FT                   /note="Nebulin 2"
FT   REPEAT          100..136
FT                   /note="Nebulin 3"
FT   REPEAT          137..172
FT                   /note="Nebulin 4"
FT   REPEAT          173..205
FT                   /note="Nebulin 5"
FT   REPEAT          206..241
FT                   /note="Nebulin 6"
FT   REPEAT          242..278
FT                   /note="Nebulin 7"
FT   REPEAT          279..313
FT                   /note="Nebulin 8"
FT   REPEAT          314..348
FT                   /note="Nebulin 9"
FT   REPEAT          349..385
FT                   /note="Nebulin 10"
FT   REPEAT          386..422
FT                   /note="Nebulin 11"
FT   REPEAT          423..459
FT                   /note="Nebulin 12"
FT   REPEAT          460..496
FT                   /note="Nebulin 13"
FT   REPEAT          497..533
FT                   /note="Nebulin 14"
FT   REPEAT          534..569
FT                   /note="Nebulin 15"
FT   REPEAT          570..599
FT                   /note="Nebulin 16"
FT   REPEAT          600..635
FT                   /note="Nebulin 17"
FT   REPEAT          636..666
FT                   /note="Nebulin 18"
FT   REPEAT          667..693
FT                   /note="Nebulin 19"
FT   REPEAT          694..728
FT                   /note="Nebulin 20"
FT   REPEAT          729..759
FT                   /note="Nebulin 21"
FT   REPEAT          760..794
FT                   /note="Nebulin 22"
FT   REPEAT          795..830
FT                   /note="Nebulin 23"
FT   DOMAIN          954..1014
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   REGION          1..24
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          836..953
FT                   /note="Linker"
FT   MOD_RES         795
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   VAR_SEQ         1..664
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15004028, ECO:0000303|PubMed:15489334"
FT                   /id="VSP_043816"
FT   VAR_SEQ         665..782
FT                   /note="TPVSMTPEIERVRRNQEQLSAVKYKGELQRGTAISDPPELKRAKENQKNISN
FT                   VYYRGQLGRATTLSVTPEMERVKKNQENISSVKYTQDHKQMKGRPSLILDTPAMRHVKE
FT                   AQNHISM -> MNPQCARCGKVVYPTEKVNCLDKYWHKGCFHCEVCKMALNMNNYKGYE
FT                   KKPYCNAHYPKQSFTTVADTPENLRLKQQSELQSQVKYKRDFEESKGRGFSIVTDTPEL
FT                   QRLKRTQEQISN (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15004028, ECO:0000303|PubMed:15489334"
FT                   /id="VSP_043817"
FT   VAR_SEQ         840..920
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15004028, ECO:0000303|PubMed:15489334"
FT                   /id="VSP_043818"
FT   VARIANT         187
FT                   /note="Q -> H (in dbSNP:rs75301590)"
FT                   /evidence="ECO:0000269|PubMed:11140941"
FT                   /id="VAR_010289"
FT   VARIANT         219
FT                   /note="A -> D (in dbSNP:rs2296610)"
FT                   /id="VAR_021887"
FT   VARIANT         351
FT                   /note="M -> V (in dbSNP:rs4025981)"
FT                   /evidence="ECO:0000269|PubMed:11140941"
FT                   /id="VAR_010290"
FT   VARIANT         378
FT                   /note="D -> H (in dbSNP:rs41277370)"
FT                   /id="VAR_051229"
FT   VARIANT         654
FT                   /note="N -> K (higher frequency of homozygotes in a cohort
FT                   of non-familial cardiomyopathy Japanese patients as
FT                   compared to healthy controls; dbSNP:rs4748728)"
FT                   /evidence="ECO:0000269|PubMed:11140941"
FT                   /id="VAR_010291"
FT   VARIANT         728
FT                   /note="T -> A (in dbSNP:rs71535732)"
FT                   /evidence="ECO:0000269|PubMed:11140941"
FT                   /id="VAR_010292"
FT   CONFLICT        53..60
FT                   /note="RYKEEFKK -> VIKKSLKS (in Ref. 2; AAF24858)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        75
FT                   /note="N -> T (in Ref. 2; AAF24858)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        129..138
FT                   /note="KHDAAKGFSD -> NMMLPRILS (in Ref. 2; AAF24858)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        439..445
FT                   /note="RASEMAS -> QPLKWQG (in Ref. 2; AAF24858)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        706..726
FT                   /note="RAKENQKNISNVYYRGQLGRA -> PKETRKTSACLLQSSAGES (in
FT                   Ref. 2; AAF24858)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        732
FT                   /note="T -> I (in Ref. 2; AAF24858)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        740
FT                   /note="K -> E (in Ref. 2; AAF24858)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        743
FT                   /note="E -> G (in Ref. 2; AAF24858)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        902..904
FT                   /note="EIY -> RDL (in Ref. 2; AAF24858)"
FT                   /evidence="ECO:0000305"
FT   STRAND          959..963
FT                   /evidence="ECO:0007829|PDB:4F14"
FT   STRAND          980..986
FT                   /evidence="ECO:0007829|PDB:4F14"
FT   STRAND          988..996
FT                   /evidence="ECO:0007829|PDB:4F14"
FT   TURN            997..1000
FT                   /evidence="ECO:0007829|PDB:4F14"
FT   STRAND          1001..1006
FT                   /evidence="ECO:0007829|PDB:4F14"
FT   HELIX           1007..1009
FT                   /evidence="ECO:0007829|PDB:4F14"
FT   STRAND          1010..1012
FT                   /evidence="ECO:0007829|PDB:4F14"
FT   MOD_RES         O76041-2:96
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
SQ   SEQUENCE   1014 AA;  116453 MW;  81712E38BC6AC9E1 CRC64;
     MRVPVFEDIK DETEEEKIGE EENEEDQVFY KPVIEDLSME LARKCTELIS DIRYKEEFKK
     SKDKCTFVTD SPMLNHVKNI GAFISEAKYK GTIKADLSNS LYKRMPATID SVFAGEVTQL
     QSEVAYKQKH DAAKGFSDYA HMKEPPEVKH AMEVNKHQSN ISYRKDVQDT HTYSAELDRP
     DIKMATQISK IISNAEYKKG QGIMNKEPAV IGRPDFEHAV EASKLSSQIK YKEKFDNEMK
     DKKHHYNPLE SASFRQNQLA ATLASNVKYK KDIQNMHDPV SDLPNLLFLD HVLKASKMLS
     GREYKKLFEE NKGMYHFDAD AVEHLHHKGN AVLQSQVKYK EEYEKNKGKP MLEFVETPSY
     QASKEAQKMQ SEKVYKEDFE KEIKGRSSLD LDKTPEFLHV KYITNLLREK EYKKDLENEI
     KGKGMELNSE VLDIQRAKRA SEMASEKEYK KDLESIIKGK GMQAGTDTLE MQHAKKAAEI
     ASEKDYKRDL ETEIKGKGMQ VSTDTLDVQR AKKASEMASQ KQYKKDLENE IKGKGMQVSM
     DIPDILRAKR TSEIYSQRKY KDEAEKMLSN YSTIADTPEI QRIKTTQQNI SAVFYKKEVG
     AGTAVKDSPE IERVKKNQQN ISSVKYKEEI KHATAISDPP ELKRVKENQK NISNLQYKEQ
     NYKATPVSMT PEIERVRRNQ EQLSAVKYKG ELQRGTAISD PPELKRAKEN QKNISNVYYR
     GQLGRATTLS VTPEMERVKK NQENISSVKY TQDHKQMKGR PSLILDTPAM RHVKEAQNHI
     SMVKYHEDFE KTKGRGFTPV VDDPVTERVR KNTQVVSDAA YKGVHPHIVE MDRRPGIIVD
     LKVWRTDPGS IFDLDPLEDN IQSRSLHMLS EKASHYRRHW SRSHSSSTFG TGLGDDRSEI
     SEIYPSFSCC SEVTRPSDEG APVLPGAYQQ SHSQGYGYMH QTSVSSMRSM QHSPNLRTYR
     AMYDYSAQDE DEVSFRDGDY IVNVQPIDDG WMYGTVQRTG RTGMLPANYI EFVN
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024